In STEP-1 (N=1,961), participants on semaglutide 2.4 mg achieved 14.9% mean body weight loss at 68 weeks compared to 2.4% with placebo [9] If applicable, documentation of failed step therapy with dates, doses, and reasons for discontinuation External Review If BCBSNC upholds the denial on internal appeal, North Carolina law entitles you to an independent external review through the NC Department of Insurance
NovoLog for type 1 diabetes With type 1 diabetes, your pancreas doesnt produce enough of a hormone called insulin
maintained endothelial function by correction of obesity-induced decreases in endothelial nitric oxide synthase (eNOS), reduced markers of hypertrophy and fibrosis
GI side effects are uniformly higher with retatrutide, reflecting the additional receptor stimulation
You do still need a prescription from your doctor to purchase the medications, but the discount is helpful because many insurance plans often do not cover the cost of the medications